News

Early research on an investigational malaria jab has sparked hopes of an effective vaccine against the disease, which kills more than 600,000 people every year.

Johnson & Johnson’s multiple myeloma treatment Velcade has been cleared as a first-line therapy in the EU, boosting the number of patients eligible for treatment with the drug.

The Prime Minister’s Council for Science and Technology has urged the NHS to be open to earlier and fuller engagement with innovative business of all sizes.

As expected, Celgene has been given the thumbs-up in Europe for its myeloma drug pomalidomide, which will be marketed as Imnovid.

Sanofi says it is taking “very seriously” allegations that some employees bribed more than 500 doctors in China six years ago.

The UK government is putting in an additional £500 million over the next two years to ensure that struggling A&E departments can cope over the winter.

Charles de Wet, Boehringer Ingelheim’s medical director for the UK and Ireland, says the company is wholeheartedly committed to data transparency but does not favour the approach being adopted by the AllTrials campaign.

GlaxoSmithKline has launched a $50 million venture capital fund that will invest in companies that pioneer medicines using electrical impulses to regulate the body’s organs and functions.

Icon, the global provider of outsourced development services based in Ireland, has formed a partnership with the National Clinical Trials and Research Centre (NCTRC) at the National Taiwan University Hospital to improve the set-up and management of clinical studies in Taiwan.

Ixchelsis, a start-up company that has come out of Pfizer’s former R&D site at Sandwich, UK, is progressing a treatment for premature ejaculation boosted by the backing of Eli Lilly.

Novo Nordisk has posted yet another strong set of figures, helped by strong sales of its diabetes drug Victoza.

One-to-one telephone health coaching does not seem to reduce hospital use and related costs for patients with long-term conditions (LTCs) – and may even lead to increased use, say UK researchers.

Sundia MediTech has entered into a strategic alliance for contract research and manufacturing services (CRAMS) in mainland China with ScinoPharm (Changshu) Pharmaceuticals.

NHS staff should be supported to learn from mistakes, and patients and carers must be put above all to make the NHS a world leader in patient safety, says a former adviser to US President Barack Obama.

Novartis has suffered a setback on getting expanded approvals for Afinitor after the drug failed in a late-stage trial as a treatment for advanced liver cancer.